Botulinum toxin injected in the gastric wall reduces body weight and food intake in rats

D. Gui, A. De Gaetano, P. Luigi Spada, A. Viggiano, E. Cassetta, A. Albanese

Research output: Contribution to journalArticle

Abstract

Background: Botulinum toxin is a powerful, long-acting inhibitor of muscular contractions in both voluntary and smooth muscle. It acts by blocking the release of the neurotransmitter acetylcholine. In the stomach, propulsive contractions of the antrum are necessary for the gastric contents to pass into the duodenum. Aims: To investigate whether intramuscular injections of botulinum toxin type A into the gastric antrum of rats would cause a reduction in food intake and hence body weight, by inhibition of gastric emptying, Materials and methods: This was a prospective, randomized, 3-way parallel group study in rats. The first group was anaesthetized, laparotomized and given 20 U of botulinum toxin type A by intramuscular injection into the gastric antrum (botulinum toxin type A group, n = 14). The second group was anaesthetized, laparotomized and injected with saline (sham group, n = 14) and the third group did not have any intervention (control group, n = 5). Food intake was measured daily for 7 weeks and body weight was measured daily for 10 weeks. Results: There was a significant difference in loss of body weight between the two treated groups (14.0 ± 8.2% botulinum toxin type A group. 4.4 ± 2.7% sham group: P <0.001). Further, the time to reach the weight nadir was significantly longer in the botulinum toxin type A group (8.7 ± 3.9 days) compared with the sham group (5.3 ± 3.8 days: P <0.04). There were no significant differences between the sham and control groups for any of the body weight parameters. The minimum dietary intake was significantly lower in the botulinum toxin type A group than in the sham group (37.8 ± 21.8% of the basal value in the botulinum toxin type A group, vs. 65.5 ± 32.0 in the sham group, P <0.05). In addition, the time to reach the nadir was significantly prolonged (8.2 ± 3.5 days, botulinum toxin type A group vs. 4.9 ± 1.7 days, sham group. P <0.001). Conclusions: The parallel reduction of body weight and food intake in botulinum toxin type A treated animals is consistent with a long lasting inhibition of the antral pump. This is probably due to slowed gastric emptying leading to early satiety. Patients with morbid obesity might benefit from endoscopic injections of botulinum toxin type A into the stomach wall.

Original languageEnglish
Pages (from-to)829-834
Number of pages6
JournalAlimentary Pharmacology and Therapeutics
Volume14
Issue number6
DOIs
Publication statusPublished - 2000

Fingerprint

Type A Botulinum Toxins
Botulinum Toxins
Stomach
Eating
Body Weight
Pyloric Antrum
Gastric Emptying
Intramuscular Injections
Control Groups
Gastrointestinal Contents
Morbid Obesity
Muscle Contraction
Duodenum
Acetylcholine
Smooth Muscle
Neurotransmitter Agents
Skeletal Muscle
Weights and Measures

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Botulinum toxin injected in the gastric wall reduces body weight and food intake in rats. / Gui, D.; De Gaetano, A.; Spada, P. Luigi; Viggiano, A.; Cassetta, E.; Albanese, A.

In: Alimentary Pharmacology and Therapeutics, Vol. 14, No. 6, 2000, p. 829-834.

Research output: Contribution to journalArticle

Gui, D. ; De Gaetano, A. ; Spada, P. Luigi ; Viggiano, A. ; Cassetta, E. ; Albanese, A. / Botulinum toxin injected in the gastric wall reduces body weight and food intake in rats. In: Alimentary Pharmacology and Therapeutics. 2000 ; Vol. 14, No. 6. pp. 829-834.
@article{02e72c27b45d4ee0aeec965727ed983e,
title = "Botulinum toxin injected in the gastric wall reduces body weight and food intake in rats",
abstract = "Background: Botulinum toxin is a powerful, long-acting inhibitor of muscular contractions in both voluntary and smooth muscle. It acts by blocking the release of the neurotransmitter acetylcholine. In the stomach, propulsive contractions of the antrum are necessary for the gastric contents to pass into the duodenum. Aims: To investigate whether intramuscular injections of botulinum toxin type A into the gastric antrum of rats would cause a reduction in food intake and hence body weight, by inhibition of gastric emptying, Materials and methods: This was a prospective, randomized, 3-way parallel group study in rats. The first group was anaesthetized, laparotomized and given 20 U of botulinum toxin type A by intramuscular injection into the gastric antrum (botulinum toxin type A group, n = 14). The second group was anaesthetized, laparotomized and injected with saline (sham group, n = 14) and the third group did not have any intervention (control group, n = 5). Food intake was measured daily for 7 weeks and body weight was measured daily for 10 weeks. Results: There was a significant difference in loss of body weight between the two treated groups (14.0 ± 8.2{\%} botulinum toxin type A group. 4.4 ± 2.7{\%} sham group: P <0.001). Further, the time to reach the weight nadir was significantly longer in the botulinum toxin type A group (8.7 ± 3.9 days) compared with the sham group (5.3 ± 3.8 days: P <0.04). There were no significant differences between the sham and control groups for any of the body weight parameters. The minimum dietary intake was significantly lower in the botulinum toxin type A group than in the sham group (37.8 ± 21.8{\%} of the basal value in the botulinum toxin type A group, vs. 65.5 ± 32.0 in the sham group, P <0.05). In addition, the time to reach the nadir was significantly prolonged (8.2 ± 3.5 days, botulinum toxin type A group vs. 4.9 ± 1.7 days, sham group. P <0.001). Conclusions: The parallel reduction of body weight and food intake in botulinum toxin type A treated animals is consistent with a long lasting inhibition of the antral pump. This is probably due to slowed gastric emptying leading to early satiety. Patients with morbid obesity might benefit from endoscopic injections of botulinum toxin type A into the stomach wall.",
author = "D. Gui and {De Gaetano}, A. and Spada, {P. Luigi} and A. Viggiano and E. Cassetta and A. Albanese",
year = "2000",
doi = "10.1046/j.1365-2036.2000.00765.x",
language = "English",
volume = "14",
pages = "829--834",
journal = "Alimentary Pharmacology and Therapeutics",
issn = "0269-2813",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "6",

}

TY - JOUR

T1 - Botulinum toxin injected in the gastric wall reduces body weight and food intake in rats

AU - Gui, D.

AU - De Gaetano, A.

AU - Spada, P. Luigi

AU - Viggiano, A.

AU - Cassetta, E.

AU - Albanese, A.

PY - 2000

Y1 - 2000

N2 - Background: Botulinum toxin is a powerful, long-acting inhibitor of muscular contractions in both voluntary and smooth muscle. It acts by blocking the release of the neurotransmitter acetylcholine. In the stomach, propulsive contractions of the antrum are necessary for the gastric contents to pass into the duodenum. Aims: To investigate whether intramuscular injections of botulinum toxin type A into the gastric antrum of rats would cause a reduction in food intake and hence body weight, by inhibition of gastric emptying, Materials and methods: This was a prospective, randomized, 3-way parallel group study in rats. The first group was anaesthetized, laparotomized and given 20 U of botulinum toxin type A by intramuscular injection into the gastric antrum (botulinum toxin type A group, n = 14). The second group was anaesthetized, laparotomized and injected with saline (sham group, n = 14) and the third group did not have any intervention (control group, n = 5). Food intake was measured daily for 7 weeks and body weight was measured daily for 10 weeks. Results: There was a significant difference in loss of body weight between the two treated groups (14.0 ± 8.2% botulinum toxin type A group. 4.4 ± 2.7% sham group: P <0.001). Further, the time to reach the weight nadir was significantly longer in the botulinum toxin type A group (8.7 ± 3.9 days) compared with the sham group (5.3 ± 3.8 days: P <0.04). There were no significant differences between the sham and control groups for any of the body weight parameters. The minimum dietary intake was significantly lower in the botulinum toxin type A group than in the sham group (37.8 ± 21.8% of the basal value in the botulinum toxin type A group, vs. 65.5 ± 32.0 in the sham group, P <0.05). In addition, the time to reach the nadir was significantly prolonged (8.2 ± 3.5 days, botulinum toxin type A group vs. 4.9 ± 1.7 days, sham group. P <0.001). Conclusions: The parallel reduction of body weight and food intake in botulinum toxin type A treated animals is consistent with a long lasting inhibition of the antral pump. This is probably due to slowed gastric emptying leading to early satiety. Patients with morbid obesity might benefit from endoscopic injections of botulinum toxin type A into the stomach wall.

AB - Background: Botulinum toxin is a powerful, long-acting inhibitor of muscular contractions in both voluntary and smooth muscle. It acts by blocking the release of the neurotransmitter acetylcholine. In the stomach, propulsive contractions of the antrum are necessary for the gastric contents to pass into the duodenum. Aims: To investigate whether intramuscular injections of botulinum toxin type A into the gastric antrum of rats would cause a reduction in food intake and hence body weight, by inhibition of gastric emptying, Materials and methods: This was a prospective, randomized, 3-way parallel group study in rats. The first group was anaesthetized, laparotomized and given 20 U of botulinum toxin type A by intramuscular injection into the gastric antrum (botulinum toxin type A group, n = 14). The second group was anaesthetized, laparotomized and injected with saline (sham group, n = 14) and the third group did not have any intervention (control group, n = 5). Food intake was measured daily for 7 weeks and body weight was measured daily for 10 weeks. Results: There was a significant difference in loss of body weight between the two treated groups (14.0 ± 8.2% botulinum toxin type A group. 4.4 ± 2.7% sham group: P <0.001). Further, the time to reach the weight nadir was significantly longer in the botulinum toxin type A group (8.7 ± 3.9 days) compared with the sham group (5.3 ± 3.8 days: P <0.04). There were no significant differences between the sham and control groups for any of the body weight parameters. The minimum dietary intake was significantly lower in the botulinum toxin type A group than in the sham group (37.8 ± 21.8% of the basal value in the botulinum toxin type A group, vs. 65.5 ± 32.0 in the sham group, P <0.05). In addition, the time to reach the nadir was significantly prolonged (8.2 ± 3.5 days, botulinum toxin type A group vs. 4.9 ± 1.7 days, sham group. P <0.001). Conclusions: The parallel reduction of body weight and food intake in botulinum toxin type A treated animals is consistent with a long lasting inhibition of the antral pump. This is probably due to slowed gastric emptying leading to early satiety. Patients with morbid obesity might benefit from endoscopic injections of botulinum toxin type A into the stomach wall.

UR - http://www.scopus.com/inward/record.url?scp=0034113160&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034113160&partnerID=8YFLogxK

U2 - 10.1046/j.1365-2036.2000.00765.x

DO - 10.1046/j.1365-2036.2000.00765.x

M3 - Article

C2 - 10848669

AN - SCOPUS:0034113160

VL - 14

SP - 829

EP - 834

JO - Alimentary Pharmacology and Therapeutics

JF - Alimentary Pharmacology and Therapeutics

SN - 0269-2813

IS - 6

ER -